709 related articles for article (PubMed ID: 33608417)
1. Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study.
Kang X; Ploner A; Pedersen NL; Bandres-Ciga S; Noyce AJ; Wirdefeldt K; Williams DM
Neurology; 2021 Mar; 96(12):e1672-e1679. PubMed ID: 33608417
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general population.
Kang X; Jiao T; Wang H; Pernow J; Wirdefeldt K
EBioMedicine; 2022 Feb; 76():103824. PubMed ID: 35074627
[TBL] [Abstract][Full Text] [Related]
3. TNF inhibitors associated with cardiovascular diseases and cardiometabolic risk factors: a Mendelian randomization study.
Liu ZY; Huang XB; Yang GM; Zhao S
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8556-8578. PubMed ID: 37782172
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor necrosis factor receptor 1 and the risk of periodontitis.
Alayash Z; Baumeister SE; Holtfreter B; Kocher T; Baurecht H; Ehmke B; Reckelkamm SL; Nolde M
Front Immunol; 2023; 14():1094175. PubMed ID: 36845132
[TBL] [Abstract][Full Text] [Related]
5. Genetically proxied inhibition of tumor necrosis factor and the risk of colorectal cancer: A drug-target mendelian randomization study.
Chen M; Chen Q; Xiao XY; Feng SJ; Wang XY; Tang TC; Zheng H
Front Pharmacol; 2022; 13():1079953. PubMed ID: 36618924
[No Abstract] [Full Text] [Related]
6. A Mendelian randomization study investigating the causal role of inflammation on Parkinson's disease.
Bottigliengo D; Foco L; Seibler P; Klein C; König IR; Del Greco M F
Brain; 2022 Oct; 145(10):3444-3453. PubMed ID: 35656776
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor mediates the impact of PM
Li M; Shi P; Yang H; Tong S; Qiu N; Yao F; Du Y; Xi S; Wang F
Ecotoxicol Environ Saf; 2024 Jan; 270():115896. PubMed ID: 38184974
[TBL] [Abstract][Full Text] [Related]
8. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Gregory AP; Dendrou CA; Attfield KE; Haghikia A; Xifara DK; Butter F; Poschmann G; Kaur G; Lambert L; Leach OA; Prömel S; Punwani D; Felce JH; Davis SJ; Gold R; Nielsen FC; Siegel RM; Mann M; Bell JI; McVean G; Fugger L
Nature; 2012 Aug; 488(7412):508-511. PubMed ID: 22801493
[TBL] [Abstract][Full Text] [Related]
9. Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
Kusters CDJ; Paul KC; Duarte Folle A; Keener AM; Bronstein JM; Bertram L; Hansen J; Horvath S; Sinsheimer JS; Lill CM; Ritz BR
Mov Disord; 2021 Oct; 36(10):2264-2272. PubMed ID: 34426982
[TBL] [Abstract][Full Text] [Related]
10. The Parkinson's Disease Mendelian Randomization Research Portal.
Noyce AJ; Bandres-Ciga S; Kim J; Heilbron K; Kia D; Hemani G; Xue A; Lawlor DA; Smith GD; Duran R; Gan-Or Z; Blauwendraat C; Gibbs JR; ; Hinds DA; Yang J; Visscher P; Cuzick J; Morris H; Hardy J; Wood NW; Nalls MA; Singleton AB
Mov Disord; 2019 Dec; 34(12):1864-1872. PubMed ID: 31659794
[TBL] [Abstract][Full Text] [Related]
11. Effect of plasma vitamin C levels on Parkinson's disease and age at onset: a Mendelian randomization study.
Liu H; Zhang Y; Zhang H; Wang L; Wang T; Han Z; Wu L; Liu G
J Transl Med; 2021 May; 19(1):221. PubMed ID: 34030714
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.
Prins BP; Abbasi A; Wong A; Vaez A; Nolte I; Franceschini N; Stuart PE; Guterriez Achury J; Mistry V; Bradfield JP; Valdes AM; Bras J; Shatunov A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Lu C; Han B; Raychaudhuri S; Bevan S; Mayes MD; Tsoi LC; Evangelou E; Nair RP; Grant SF; Polychronakos C; Radstake TR; van Heel DA; Dunstan ML; Wood NW; Al-Chalabi A; Dehghan A; Hakonarson H; Markus HS; Elder JT; Knight J; Arking DE; Spector TD; Koeleman BP; van Duijn CM; Martin J; Morris AP; Weersma RK; Wijmenga C; Munroe PB; Perry JR; Pouget JG; Jamshidi Y; Snieder H; Alizadeh BZ
PLoS Med; 2016 Jun; 13(6):e1001976. PubMed ID: 27327646
[TBL] [Abstract][Full Text] [Related]
13. Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis.
Jiang L; Li JC; Tang BS; Guo JF
Eur J Neurol; 2023 Nov; 30(11):3471-3477. PubMed ID: 37159496
[TBL] [Abstract][Full Text] [Related]
14. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
Peter I; Dubinsky M; Bressman S; Park A; Lu C; Chen N; Wang A
JAMA Neurol; 2018 Aug; 75(8):939-946. PubMed ID: 29710331
[TBL] [Abstract][Full Text] [Related]
15. Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration.
Han X; Ong JS; An J; Hewitt AW; Gharahkhani P; MacGregor S
Eur J Epidemiol; 2020 Feb; 35(2):139-146. PubMed ID: 31900758
[TBL] [Abstract][Full Text] [Related]
16. Lack of Causal Associations of Inflammatory Bowel Disease with Parkinson's Disease and Other Neurodegenerative Disorders.
Zeng R; Wang J; Zheng C; Jiang R; Tong S; Wu H; Zhuo Z; Yang Q; Leung FW; Sha W; Chen H
Mov Disord; 2023 Jun; 38(6):1082-1088. PubMed ID: 36959736
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and heart failure: a two-sample Mendelian randomization study.
Remmelzwaal S; van Oort S; Handoko ML; van Empel V; Heymans SRB; Beulens JWJ
J Cardiovasc Med (Hagerstown); 2022 Nov; 23(11):728-735. PubMed ID: 36166332
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
Pierik M; Vermeire S; Steen KV; Joossens S; Claessens G; Vlietinck R; Rutgeerts P
Aliment Pharmacol Ther; 2004 Aug; 20(3):303-10. PubMed ID: 15274667
[TBL] [Abstract][Full Text] [Related]
19. TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice.
Liu CY; Tam SS; Huang Y; Dubé PE; Alhosh R; Girish N; Punit S; Nataneli S; Li F; Bender JM; Washington MK; Polk DB
Cell Rep; 2020 Oct; 33(3):108275. PubMed ID: 33086075
[TBL] [Abstract][Full Text] [Related]
20. Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study.
Domenighetti C; Sugier PE; Ashok Kumar Sreelatha A; Schulte C; Grover S; Mohamed O; Portugal B; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Duga S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Kawamura Y; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Correia Guedes L; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen NL; Ran C; Belin AC; Puschmann A; Hellberg C; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Krüger R; Gasser T; Sharma M; Elbaz A;
Mov Disord; 2022 Apr; 37(4):857-864. PubMed ID: 34997937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
